JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.65B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.08B |
| 3 |
Microsoft
MSFT
|
+$2.05B |
| 4 |
Vanguard Total International Bond ETF
BNDX
|
+$1.64B |
| 5 |
Micron Technology
MU
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$2.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.11B |
| 3 |
Progressive
PGR
|
+$1.64B |
| 4 |
Salesforce
CRM
|
+$1.54B |
| 5 |
Adobe
ADBE
|
+$1.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.15% |
| 2 | Technology | 24.03% |
| 3 | Healthcare | 9.24% |
| 4 | Consumer Discretionary | 8.79% |
| 5 | Financials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2726
CALL
Target
TGT
$70.9B
| $6.68M | ﹤0.01% |
45,100
+21,300
| +89% | +$3.35M |
2020 Q3
15 quarters
|
|
2727
Frontdoor
FTDR
$5.32B
| $6.67M | ﹤0.01% |
197,408
-67,163
| -25% | -$2.26M |
2018 Q4
22 quarters
|
|
|
ODP
2728
DELISTED
ODP
ODP
| $6.66M | ﹤0.01% |
169,671
-248,346
| -59% | -$11.1M |
2013 Q2
44 quarters
|
|
|
INN
2729
Summit Hotel Properties
INN
$649M
| $6.65M | ﹤0.01% |
1,110,051
+514,877
| +87% | +$3.15M |
2014 Q3
39 quarters
|
|
2730
Taysha Gene Therapies
TSHA
$1.51B
| $6.64M | ﹤0.01% |
2,963,553
+2,869,812
| +3,061% | +$8.35M |
2020 Q4
14 quarters
|
|
2731
Main Street Capital
MAIN
$5.15B
| $6.63M | ﹤0.01% |
131,289
-1,129
| -0.9% | -$55.1K |
2015 Q4
34 quarters
|
|
2732
Arcturus Therapeutics
ARCT
$370M
| $6.62M | ﹤0.01% |
272,007
-45,544
| -14% | -$1.38M |
2019 Q2
20 quarters
|
|
2733
PUT
Southwest Airlines
LUV
$20.8B
| $6.61M | ﹤0.01% |
231,200
-326,600
| -59% | -$9.11M |
2022 Q3
7 quarters
|
|
2734
PUT
Ionis Pharmaceuticals
IONS
$7.24B
| $6.61M | ﹤0.01% |
138,700
+43,800
| +46% | +$1.8M |
2023 Q3
3 quarters
|
|
|
DEA
2735
Easterly Government Properties
DEA
$1.11B
| $6.61M | ﹤0.01% |
213,672
-46,468
| -18% | -$1.37M |
2015 Q4
34 quarters
|
|
2736
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
| $6.6M | ﹤0.01% |
107,123
-16,466
| -13% | -$1.03M |
2013 Q2
44 quarters
|
|
2737
CrossAmerica Partners
CAPL
$831M
| $6.59M | ﹤0.01% |
332,240
-128,823
| -28% | -$2.73M |
2022 Q3
7 quarters
|
|
2738
United Microelectronic
UMC
$65.9B
| $6.59M | ﹤0.01% |
752,736
+207,901
| +38% | +$1.71M |
2020 Q2
16 quarters
|
|
2739
CALL
Crocs
CROX
$5.66B
| $6.57M | ﹤0.01% |
45,000
-4,400
| -9% | -$617K |
2022 Q3
7 quarters
|
|
2740
iShares Ultra Short Duration Bond Active ETF
ICSH
$8.82B
| $6.55M | ﹤0.01% |
129,674
-39,872
| -24% | -$2.01M |
2020 Q1
17 quarters
|
|
2741
CALL
HubSpot
HUBS
$10.7B
| $6.55M | ﹤0.01% |
11,100
+1,100
| +11% | +$675K |
2024 Q1
1 quarter
|
|
2742
WisdomTree
WT
$3.69B
| $6.54M | ﹤0.01% |
660,194
+429,191
| +186% | +$4.04M |
2014 Q2
40 quarters
|
|
2743
US Physical Therapy
USPH
$1.25B
| $6.54M | ﹤0.01% |
70,761
-22,183
| -24% | -$2.24M |
2015 Q4
34 quarters
|
|
2744
Pulmonx
LUNG
$78.6M
| $6.53M | ﹤0.01% |
1,030,520
+765,945
| +290% | +$5.89M |
2020 Q4
14 quarters
|
|
2745
Algonquin Power & Utilities
AQN
$3.93B
| $6.51M | ﹤0.01% |
1,110,430
-610,381
| -35% | -$3.78M |
2017 Q1
29 quarters
|
|
2746
SunCoke Energy
SXC
$840M
| $6.48M | ﹤0.01% |
660,816
-122,794
| -16% | -$1.27M |
2013 Q2
44 quarters
|
|
2747
Travere Therapeutics
TVTX
$5.37B
| $6.46M | ﹤0.01% |
785,295
+436,135
| +125% | +$2.94M |
2016 Q4
30 quarters
|
|
2748
Nuveen Core Plus Bond ETF
NCPB
$53.4M
| $6.45M | ﹤0.01% |
+258,922
| New | +$6.42M |
2024 Q2
0 quarters
|
|
2749
Sunrun
RUN
$1.86B
| $6.45M | ﹤0.01% |
543,527
-407,697
| -43% | -$4.99M |
2016 Q2
32 quarters
|
|
2750
CALL
AstraZeneca
AZN
$243B
| $6.41M | ﹤0.01% |
41,100
+11,100
| +37% | +$1.67M |
2023 Q3
3 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2024 Portfolio in Review
As of Q2 2024, JP Morgan Chase held 7,917 positions worth $1.22T, up 3% from $1.18T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q2 2024 filing shows 549 new, 2,506 increased, 3,286 reduced and 578 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $2.4B.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2024 buy was BlackRock Flexible Income ETF: 6,829,171 shares worth $357M.
- JP Morgan Chase added most to Apple in Q2 2024, an estimated $4.65B increase.
- JP Morgan Chase's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.11B.
- JP Morgan Chase fully exited JP Morgan Alerian MLP Index ETN 5/24/24 in Q2 2024, selling an estimated $2.4B.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.22T portfolio in Q2 2024.
- JP Morgan Chase opened 549 new positions and closed 578 in Q2 2024.
- JP Morgan Chase's portfolio value rose 3% quarter-over-quarter to $1.22T.
Based on JP Morgan Chase's 13F filing for Q2 2024, filed 12 Aug 2024.